Annual Cash & Cash Equivalents
$2.68 M
+$1.93 M+257.90%
December 1, 2023
Summary
- As of February 7, 2025, TNFA annual cash & cash equivalents is $2.68 million, with the most recent change of +$1.93 million (+257.90%) on December 1, 2023.
- During the last 3 years, TNFA annual cash & cash equivalents has risen by +$2.53 million (+1707.82%).
- TNFA annual cash & cash equivalents is now at all-time high.
Performance
TNFA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.19 M
+$656.40 K+122.46%
September 1, 2024
Summary
- As of February 7, 2025, TNFA quarterly cash and cash equivalents is $1.19 million, with the most recent change of +$656.40 thousand (+122.46%) on September 1, 2024.
- Over the past year, TNFA quarterly cash and cash equivalents has dropped by -$1.49 million (-55.52%).
- TNFA quarterly cash and cash equivalents is now -55.52% below its all-time high of $2.68 million, reached on December 1, 2023.
Performance
TNFA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TNFA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +257.9% | -55.5% |
| 3 y3 years | +1707.8% | +284.8% |
| 5 y5 years | +1707.8% | +109.4% |
TNFA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +382.2% | -55.5% | +1171.2% |
| 5 y | 5-year | at high | +1707.8% | -55.5% | +1171.2% |
| alltime | all time | at high | +1707.8% | -55.5% | +1171.2% |
TNF Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.19 M(+122.5%) |
| Jun 2024 | - | $536.00 K(+137.5%) |
| Mar 2024 | - | $225.70 K(-91.6%) |
| Dec 2023 | $2.68 M(+257.9%) | $2.68 M(+798.8%) |
| Sep 2023 | - | $298.30 K(+218.0%) |
| Jun 2023 | - | $93.80 K(-50.2%) |
| Mar 2023 | - | $188.50 K(-74.8%) |
| Dec 2022 | $749.10 K | $749.10 K(+141.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $309.90 K(-72.2%) |
| Jun 2022 | - | $1.12 M(-6.2%) |
| Mar 2022 | - | $1.19 M(+113.9%) |
| Dec 2021 | $556.00 K(+274.9%) | $556.00 K(-59.6%) |
| Sep 2021 | - | $1.38 M(-35.4%) |
| Jun 2021 | - | $2.13 M(+273.6%) |
| Mar 2021 | - | $569.40 K(+284.0%) |
| Dec 2020 | $148.30 K | $148.30 K |
FAQ
- What is TNF Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is TNF Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is TNF Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TNFA is $2.68 M
What is the all time high annual cash & cash equivalents for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual cash & cash equivalents is $2.68 M
What is TNF Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TNFA annual cash & cash equivalents has changed by +$1.93 M (+257.90%)
What is TNF Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TNFA is $1.19 M
What is the all time high quarterly cash and cash equivalents for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly cash and cash equivalents is $2.68 M
What is TNF Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, TNFA quarterly cash and cash equivalents has changed by -$1.49 M (-55.52%)